EBOS Group Limited (EBOSY) Stock

About EBOS Group Limited

EBOS Group Limited, established in 1922 and headquartered in Docklands, Australia, operates as a prominent marketer, wholesaler, and distributor of a broad spectrum of healthcare, medical, pharmaceutical, and animal care products. Its operations span Australia, New Zealand, and Southeast Asia, structured primarily around its Healthcare and Animal Care divisions. The Healthcare segment offers a comprehensive suite of services and products. These include intricate healthcare logistics, medication management systems, and specialized pharmacy management software. The software solutions cover various aspects such as loyalty programs, generics management, regulatory compliance, business intelligence, and in-store retail operations. EBOS also provides strategic health communications, targeted programs, and expert consultancy. The company is committed to delivering community-focused healthcare initiatives and supplies an extensive array of wellness products, including vitamins, minerals, supplements, herbal teas, natural oral care items, and functional foods like molasses and manuka honey. For independent pharmacies, EBOS offers the "Pharmacy Choice" integrated retail program and "healthSAVE," a community pharmacy banner aimed at bolstering retail business performance. Its client roster for health and wellness products is diverse, encompassing public and private hospitals, day surgery centers, general practices, aged care facilities, specialist clinics, government bodies, and non-profit health agencies, alongside critical clinical supplies. Additionally, EBOS extends its pharmacy services to various institutions, including private and public hospitals, cancer treatment centers, correctional facilities, and veterinary clinics. Further specialized offerings comprise allograft solutions, extensive healthcare distribution and warehousing services, clinical trial management and logistics, product registration support, as well as aesthetic healthcare devices, medical-grade cosmeceuticals, injectables, and a full range of surgical devices and medical consumables. Within the Animal Care segment, EBOS provides a wide selection of pet nutrition, treats, cleaning, and grooming products and accessories. It also functions as a significant wholesaler of veterinary products, catering to companion animals, livestock (production animals), and equine athletes. The company was originally incorporated as Early Bros Dental & Surgical Supplies Ltd. before adopting its current name, EBOS Group Limited, in 1986.

EBOS Group Limited is headquartered in AU.

EBOS Group Limited (EBOSY) stock trades at $26.00 with a market capitalization of $1.33B. The stock is valued at a price-to-earnings (P/E) ratio of 18.22, price-to-book of 1.45, price-to-sales of 0.26. Over the past 52 weeks the stock has ranged between $24.13 and $46.64, and currently trades 44.3% below its 52-week high. It pays a dividend yielding 5.27%.

On profitability, EBOS Group Limited generates a return on equity (ROE) of 8.16%, return on capital employed of 7.58%, an operating margin of 2.45%, a net profit margin of 1.43%.

Official website: www.ebosgroup.com